NO874040L - Behandlet lipidregulator. - Google Patents

Behandlet lipidregulator.

Info

Publication number
NO874040L
NO874040L NO874040A NO874040A NO874040L NO 874040 L NO874040 L NO 874040L NO 874040 A NO874040 A NO 874040A NO 874040 A NO874040 A NO 874040A NO 874040 L NO874040 L NO 874040L
Authority
NO
Norway
Prior art keywords
cholestyramine
lipid
approx
gemfibrozil
resin
Prior art date
Application number
NO874040A
Other languages
English (en)
Norwegian (no)
Other versions
NO874040D0 (no
Inventor
Isaac Ghebre-Sellassie
Robert H Gordon
Mahdi B Fawzi
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO874040D0 publication Critical patent/NO874040D0/no
Publication of NO874040L publication Critical patent/NO874040L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Confectionery (AREA)
NO874040A 1986-09-26 1987-09-25 Behandlet lipidregulator. NO874040L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91290286A 1986-09-26 1986-09-26

Publications (2)

Publication Number Publication Date
NO874040D0 NO874040D0 (no) 1987-09-25
NO874040L true NO874040L (no) 1988-03-28

Family

ID=25432663

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874040A NO874040L (no) 1986-09-26 1987-09-25 Behandlet lipidregulator.

Country Status (10)

Country Link
EP (1) EP0261693A1 (da)
JP (1) JPS63152321A (da)
KR (1) KR880003628A (da)
AU (1) AU7894887A (da)
DK (1) DK504187A (da)
FI (1) FI874164L (da)
IE (1) IE872589L (da)
NO (1) NO874040L (da)
PT (1) PT85775B (da)
ZA (1) ZA876640B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372823A (en) * 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
US4956182A (en) * 1989-03-16 1990-09-11 Bristol-Myers Company Direct compression cholestyramine tablet and solvent-free coating therefor
EP0409432A3 (en) * 1989-07-20 1991-12-11 Warner-Lambert Company Confectionery delivery system
IL95574A (en) 1989-09-09 1994-11-11 Knoll Ag Colestyramine preparation
EP0447362A1 (en) * 1990-03-13 1991-09-18 Warner-Lambert Company Improved ingestible anion exchange resin delivery system compositions containing adipic acid
EP0462067A1 (en) * 1990-06-15 1991-12-18 Warner-Lambert Company Gemfibrozil formulations
AU1042495A (en) * 1993-12-08 1995-06-27 Vitaphore Corporation Microsphere drug delivery system
TWI241195B (en) * 2000-04-10 2005-10-11 Shionogi & Co Preventive agent for bile acidic diarrhea
PE20180690A1 (es) 2015-04-27 2018-04-23 Intercept Pharmaceuticals Inc Composiciones de acido obeticolico y metodos de uso

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH556154A (fr) * 1972-09-05 1974-11-29 Derobert Pierre A Etablissemen Fermoir de securite.
JPS5867616A (ja) * 1981-10-15 1983-04-22 Tanabe Seiyaku Co Ltd 腸溶性マイクロカプセル
CA1265785A (en) * 1984-06-04 1990-02-13 Kumi Yoshida Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them

Also Published As

Publication number Publication date
FI874164A0 (fi) 1987-09-23
FI874164A7 (fi) 1988-03-27
DK504187D0 (da) 1987-09-25
EP0261693A1 (en) 1988-03-30
PT85775B (pt) 1990-07-31
AU7894887A (en) 1988-03-31
DK504187A (da) 1988-03-27
IE872589L (en) 1988-03-26
NO874040D0 (no) 1987-09-25
FI874164L (fi) 1988-03-27
ZA876640B (en) 1988-03-08
JPS63152321A (ja) 1988-06-24
KR880003628A (ko) 1988-05-28
PT85775A (en) 1987-10-01

Similar Documents

Publication Publication Date Title
US4814354A (en) Lipid regulating agents
KR100201767B1 (ko) 혈장 약물 농도의 신속한 초기 증가량을 시현하는 24시간 경구용 오피오이드 제형을 투여함으로써 통증을 치료하는 방법
US4221778A (en) Prolonged release pharmaceutical preparations
JPS62298533A (ja) 高コレステロ−ル血症治療薬およびその製造方法
PT85353B (pt) Processo de preparacao de composicoes farmaceuticas de libertacao controlada e de matriz a base de alcool alifatico e resina acrilica
WO2000013672A9 (en) New solid dose form of nanoparticulate naproxen
EP1204406A2 (en) Opioid sustained-released formulation
HU218673B (hu) Opioid analgetikumot tartalmazó elnyújtott hatóanyag-felszabadítású orális gyógyszerkészítmény és eljárás előállítására
JPH0157086B2 (da)
SE453797B (sv) Terapeutisk, solid enhetsdoseringsform med forlengt utlosningsmonster vars berarmaterial innehaller hydroxypropylmetylcellulosa med hog molekyler vikt
PT2050445E (pt) Composição farmacêutica de fenofibrato apresentando uma biodisponibilidade elevada e processo para a sua preparação
US20100273884A1 (en) Method for stable and controlled delivery of (-)-hydroxycitric acid
WO2000027385A1 (en) Dispersible compositions containing l-dopa ethyl ester
IE922365A1 (en) Improved oral dosing formulations of dideoxy purine¹nucleosides
JPH0625064B2 (ja) 制御放出塩化カリウム
NO874040L (no) Behandlet lipidregulator.
WO1997033574A1 (fr) Comprimes a liberation prolongee a base de valproate metallique
JP2000504724A (ja) キトサンとニコチン酸を含む多機能性脂肪吸収剤及び血液コレステロール低下製剤
JPH0733682A (ja) 新規複合体、それを担体として利用する徐放性製剤
CA2645574C (en) A medicine used for curing hyperphosphatemia and its preparation method
JPH07507293A (ja) ヒスタミンｈ↓２−受容体アンタゴニストおよび陽イオン交換体複合体による組成物
US8367864B2 (en) Dimeric double metal salts of (−)-hydroxycitric acid, methods of making and uses of same
JP2005516943A (ja) 経口投与に適した医薬品懸濁液
RU2209087C2 (ru) Агент для пролонгирования действия лекарственного препарата и лекарственная композиция на его основе
AU627335B2 (en) Aspirin granules with gastroprotectant coating